New ETF Book by Larry Connors - Click here to read more
At the ChinaTrials Global Clinical Development Summit, November 8-10, in Beijing, China, Phase Forward (booth # 22) Regional Director and General Manager Jon Carrano will moderate a panel on EDC in China. Session details are as follows:
Who: Jon Carrano, Ph.D., Regional Director and General Manager, Phase Forward (Moderator) What: "Electronic Data Capture and Clinical Data Management in China" When: Tuesday, November 10, 10:10-11:10 a.m. local time
At CBI's 5th Forum on Patient Reported Outcomes, November 17-18, in Philadelphia, Pa., Phase Forward will exhibit its late phase solutions and Vice President and Conference Chair Scott Dixon will participate in the following session:
Who: Scott Dixon, Vice President, Outcome Logix Group, Phase Forward (Moderator) What: "Recall Period -- What Works and What Doesn't?" When: Wednesday, November 18, 9:00-9:45 a.m. Eastern time
As Conference Chair, Mr. Dixon will also deliver opening remarks on the first day of the conference at 1:15 p.m. and on the second day at 8:00 a.m.
In addition to its speaking engagements, Phase Forward will participate in the following conferences throughout the month of November:
What: 8th Annual Partnerships in Clinical Trials When: November 4-5, Rotterdam, The Netherlands Where: Booth # 71
What: American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS) When: November 8-12, Los Angeles, Calif. Where: Booth # 702
What: CDISC Interchange North America When: November 9-13, Baltimore, Md. Where: Booth # 7
What: 2nd DIA Conference on Signal Detection and Data Mining When: November 16-18, New York, N.Y.
Members of the media interested in speaking with Phase Forward should contact Maria Sumner at +44 1628 640743 or maria.sumner@phaseforward.com or Meghan Locke at 781-672-3147 or mlocke@chenpr.com.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
SOURCE: Phase Forward
Phase Forward Elaine Maynard, 781-902-4371 elaine.maynard@phaseforward.com or CHEN PR, Inc. Meghan Locke, 781-672-3147 mlocke@chenpr.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
